In8Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.41

-0.02 (-1.40%)

As of Jun 30, 10:48 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +2,778.0% upside

Low Target $25.27

Average Target $40.58

High Target $56.74

Current Price $1.41

Current
$1.41

Target
$40.58

$25.27 $40.58 avg $56.74

Scenario Analysis

Bear Case

$25.27

1,692.2%

Low target

Base Case

$40.58

+2,778.0%

Avg target

Bull Case

$56.74

+3,924.1%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.73

-48.4% from high

52-Week Low

$1.17

+20.5% from low

Target vs 52W High

$40.58

+1,386.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%